Nucleus Network is Australia’s largest and only multi-site Phase 1 clinical research organisation and the only Clinical Pharmacology specialist globally with facilities in Australia, the USA, and the UK.

For over two decades, Nucleus Network has been conducting Phase 1 clinical trials for Biotechnology and Pharmaceutical Companies from across the globe, including the USA, China, Europe, Japan, South Korea, and Taiwan.

Recognized as Phase 1 clinical trial experts, we operate over 200 beds, and have overseen more than 1,500 trials, of which 50% are first-in-human.

In addition to FIH program, our extensive experience also includes the conduct of DDI, FE, Vaccine, Biosimilar, Renal Impairment, and ethnobridging studies.

Our Australian Phase 1 facilities are in Melbourne, Brisbane, and Sydney. Our clinical unit in the USA is in Minneapolis, and our UK unit is in London.

All five clinics are strategically co-located within leading medical, research and biotech precincts; the Alfred Hospital in Melbourne, the Royal Brisbane and Women’s Hospital in Brisbane, the Royal North Shore Hospital in Sydney, Medical Alley in Minneapolis, and Central Middlesex Hospital in London.

Why work with us

Biggest Capacity providing flexibility and speed of recruitment:

Nucleus Network currently have the largest number of dedicated early phase clinical beds in the Australia (~200) and also manages the largest healthy volunteer database where there are in excess of 800k individuals aged between 18-80 years old.

Diverse pool of inhouse Principal Investigators:

Nucleus Network has a total of 9 in house PIs with expertise across infectious diseases, general medicine, neurology, clinical pharmacology and oncology

Most extensive experience:

Nucleus Network has conducted in excess of 1,500 clinical trials since its inception in 2002 making it the most experience dedicated clinical trial operator in Australia. Our sites in the USA and UK have 20 and 30 years' experience, respecitvely. Additionally, with operations across Australia, the UK, and the USA, Nucleus provides a global solution within the same organization.